KR100662660B1 - 사이토메가로바이러스 ie 인헨서/프로모터의 활성을촉진하는 올리고뉴크레오타이드 - Google Patents
사이토메가로바이러스 ie 인헨서/프로모터의 활성을촉진하는 올리고뉴크레오타이드 Download PDFInfo
- Publication number
- KR100662660B1 KR100662660B1 KR1020030056227A KR20030056227A KR100662660B1 KR 100662660 B1 KR100662660 B1 KR 100662660B1 KR 1020030056227 A KR1020030056227 A KR 1020030056227A KR 20030056227 A KR20030056227 A KR 20030056227A KR 100662660 B1 KR100662660 B1 KR 100662660B1
- Authority
- KR
- South Korea
- Prior art keywords
- cmv
- cpg
- oligonucleotide
- enhancer
- promoter
- Prior art date
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
Claims (6)
- 사이토메가로바이러스(CMV) 이미디어트 얼리 인헨서/프로모터 활성을 촉진시키는 CpG 서열을 포함하는 올리고뉴크레오타이드.
- 제 1항에 있어서, 상기의 올리고뉴크레오타이드는 서열목록 1, 서열목록 2, 및 서열목록3으로 구성된 군으로부터 선택된 하나의 올리고뉴크레오타이드인 것을 특징으로 하는 올리고뉴크레오타이드.
- 제 2항에 있어서, 상기의 올리고뉴크레오타이드는 서열목록 1인 것을 특징으로 하는 올리고뉴크레오타이드.
- 제1항 내지 제 3항 중 임의의 한 항에서 선택된 올리고뉴크레오타이드를 이용하여 사이토메가로바이러스(CMV) 이미디어트 얼리 인헨서/프로모터 활성을 촉진시키는 방법.
- 제 4항에 있어서, 상기 올리고뉴크레오타이드의 유효농도는 0.1∼ 10uM인 것(농도 범위는 가능할 것으로 예상되는 범위를 기재하여 주기 바람)을 특징으로 하는 사이토메가로바이러스(CMV) 이미디어트 얼리 인헨서/프로모터 활성을 촉진시키는 방법.
- 제 4항에 있어서, 상기의 올리고뉴크레오타이드의 처리시간은 2∼24시간인 것을 특징으로 하는 사이토메가로바이러스(CMV) 이미디어트 얼리 인헨서/프로모터 활성을 촉진시키는 방법.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020030056227A KR100662660B1 (ko) | 2003-08-13 | 2003-08-13 | 사이토메가로바이러스 ie 인헨서/프로모터의 활성을촉진하는 올리고뉴크레오타이드 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020030056227A KR100662660B1 (ko) | 2003-08-13 | 2003-08-13 | 사이토메가로바이러스 ie 인헨서/프로모터의 활성을촉진하는 올리고뉴크레오타이드 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20050018720A KR20050018720A (ko) | 2005-02-24 |
KR100662660B1 true KR100662660B1 (ko) | 2007-01-02 |
Family
ID=37228135
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020030056227A KR100662660B1 (ko) | 2003-08-13 | 2003-08-13 | 사이토메가로바이러스 ie 인헨서/프로모터의 활성을촉진하는 올리고뉴크레오타이드 |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100662660B1 (ko) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6339068B1 (en) | 1997-05-20 | 2002-01-15 | University Of Iowa Research Foundation | Vectors and methods for immunization or therapeutic protocols |
-
2003
- 2003-08-13 KR KR1020030056227A patent/KR100662660B1/ko active IP Right Grant
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6339068B1 (en) | 1997-05-20 | 2002-01-15 | University Of Iowa Research Foundation | Vectors and methods for immunization or therapeutic protocols |
Non-Patent Citations (1)
Title |
---|
논문 |
Also Published As
Publication number | Publication date |
---|---|
KR20050018720A (ko) | 2005-02-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Kim et al. | Promoter sequences of the human transforming growth factor-β1 gene responsive to transforming growth factor-β1 autoinduction | |
Gopalakrishnan et al. | Differential regulation of respiratory chain subunits by a CREB-dependent signal transduction pathway. Role of cyclic AMP in cytochrome c and COXIV gene expression. | |
Vyhlidal et al. | Transcriptional activation of transforming growth factor alpha by estradiol: requirement for both a GC-rich site and an estrogen response element half-site | |
Lenardo et al. | Repression of the IgH enhancer in teratocarcinoma cells associated with a novel octamer factor | |
Atwood et al. | Interaction of the human polyomavirus, JCV, with human B-lymphocytes | |
Singh et al. | A nuclear factor that binds to a conserved sequence motif in transcriptional control elements of immunoglobulin genes | |
Kim et al. | Post-transcriptional regulation of the human transforming growth factor-beta 1 gene. | |
Iverson et al. | Clustered point mutation analysis of the rat prolactin promoter | |
Carey et al. | Transcriptional synergy by the Epstein-Barr virus transactivator ZEBRA | |
Richard et al. | Identification of a retinoic acid response element in the human oxytocin promoter. | |
Mori et al. | Identification of APOBEC3B promoter elements responsible for activation by human papillomavirus type 16 E6 | |
Galvagni et al. | Sp1 and Sp3 physically interact and co-operate with GABP for the activation of the utrophin promoter | |
Yamauchi et al. | AP-1 regulation of the rat bone sialoprotein gene transcription is mediated through a TPA response element within a glucocorticoid response unit in the gene promoter | |
Burbach et al. | Repression of estrogen-dependent stimulation of the oxytocin gene by chicken ovalbumin upstream promoter transcription factor I. | |
Lee et al. | Activation of the human endogenous retrovirus W long terminal repeat by herpes simplex virus type 1 immediate early protein 1 | |
CZ41897A3 (en) | Structures of nucleic acids for controlled expression of genes, cells containing such structures and their use for preparing medicaments | |
Kitajima et al. | Human T-cell leukemia virus type I tax transformation is associated with increased uptake of oligodeoxynucleotides in vitro and in vivo. | |
Rothofsky et al. | CROC-1 encodes a protein which mediates transcriptional activation of the human FOS promoter | |
Clark et al. | Interaction of enhancer-binding protein EBP1 (NF-kappa B) with the human immunodeficiency virus type 1 enhancer | |
Stein et al. | Regulation of transcription‐factor activity during growth and differentiation: Involvement of the nuclear matrix in concentration and localization of promoter binding proteins | |
Ronai et al. | Identification of ultraviolet-inducible proteins that bind to a TGACAACA sequence in the polyoma virus regulatory region | |
Ghosh et al. | The dual role of helix–loop–helix-zipper protein USF in ribosomal RNA gene transcription in vivo | |
Vanacker et al. | Transactivation of a cellular promoter by the NS1 protein of the parvovirus minute virus of mice through a putative hormone-responsive element | |
KR100662660B1 (ko) | 사이토메가로바이러스 ie 인헨서/프로모터의 활성을촉진하는 올리고뉴크레오타이드 | |
Ben-Or et al. | Involvement of a C/EBP-like protein in the acquisition of responsiveness to glucocorticoid hormones during chick neural retina development |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
N231 | Notification of change of applicant | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20121115 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20131014 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20140925 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20151023 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20161007 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20170925 Year of fee payment: 12 |
|
FPAY | Annual fee payment |
Payment date: 20181017 Year of fee payment: 13 |